UNITED STATES | ||
________________________________ | ||
FORM 8-K | ||
CURRENT REPORT | ||
PURSUANT TO SECTION 13 OR 15(d) OF THE | ||
DATE OF REPORT (Date of earliest event reported): November 14, 2008 | ||
IGI LABORATORIES, INC. | ||
(Exact name of registrant as specified in charter) | ||
DELAWARE | 001-08568 | 01-0355758 |
(State or Other Jurisdiction of | (Commission | (I.R.S. Employer |
Incorporation) | file number) | Identification Number) |
105 Lincoln Avenue | |
Buena, New Jersey 08310 | |
(Address of principal executive offices)(Zip Code) | |
(856) 697-1441 | |
(Registrant's telephone number, including area code) | |
Not Applicable | |
(Former name or former address, if changed since last report) | |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: | |
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
<PAGE>
Item 2.02. | Results of Operations and Financial Condition. |
On November 14, 2008, IGI Laboratories, Inc. (the "Company") issued a press release announcing the Company's earnings for the third quarter ended September 30, 2008 and certain other information. A copy of the press release is attached hereto as Exhibit 99.1. The press release is being furnished and shall not be deemed to be filed. | |
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits | |
Exhibit Number | Description of Exhibit |
Exhibit 99.1 | IGI Laboratories, Inc. Press Release dated November 14, 2008 |
<PAGE>
SIGNATURE | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. | ||
IGI, INC. | ||
Date: November 14, 2008 | By: /s/ Justine Kostka | |
Name: Justine Kostka | ||
Title: Acting Principal |
<PAGE>
EXHIBIT INDEX |
Exhibit Number | Description of Exhibit |
99.1 | IGI Laboratories, Inc. Press Release dated November 14, 2008 |